| [1] |
|
| [2] |
Shoraka M, Wang S, Carbajal-Mamani SL, et al. Oncologic outcomes in older women with endometrial carcinoma (≥70 years) [J]. J Obstet Gynaecol, 2022, 42(6): 2127-2133. DOI: 10.1080/01443615.2022.2033962.
|
| [3] |
Ram S, Lavie M, Assouline A, et al. Identifying risk factors for postoperative complications following staging surgery for endometrial cancer [J]. J Gynecol Obstet Hum Reprod, 2025, 54(6): 102949. DOI: 10.1016/j.jogoh.2025.102949.
|
| [4] |
|
| [5] |
Alemdaroglu S, Durdag GD, Baran SY, et al. Prognostic factors of endometrial cancer in elderly patient group and their effects on survival [J]. North Clin Istanb, 2021, 8(4): 345-353. DOI: 10.14744/nci.2020.47154.
|
| [6] |
|
| [7] |
|
| [8] |
Kokts-Porietis RL, Elmrayed S, Brenner DR, et al. Obesity and mortality among endometrial cancer survivors: a systematic review and Meta-analysis [J]. Obes Rev, 2021, 22(12): e13337. DOI: 10.1111/obr.13337.
|
| [9] |
Åkesson Å， Carlsson T, Kristiansen I, et al. Recurrence and survival in endometrioid endometrial cancer [J]. Gynecol Oncol, 2023, 171(1): 123-134. DOI: 10.1016/j.ygyno.2023.01.012.
|
| [10] |
Wang N, Zhang J, Fan X, et al. Identification of risk factors for the prognosis of Chinese patients with endometrial carcinoma [J]. Medicine, 2021, 100(38): e27305. DOI: 10.1097/MD.0000000000027305.
|
| [11] |
Yunokawa M, Onda T, Ishikawa M, et al. Current treatment status of older patients with gynecological cancers [J]. Jpn J Clin Oncol, 2022, 52(8): 825-832. DOI: 10.1093/jjco/hyac082.
|
| [12] |
Liyanage J, Qiu Q, Zhang H, et al. Accuracy of MRI in predicting deep myometrial invasion in endometrial cancer and the influence of leiomyoma, adenomyosis and the microcystic elongated and fragmented tumour pattern [J]. J Med Imaging Radiat Oncol, 2024, 68(3): 235-242. DOI: 10.1111/1754-9485.13622.
|
| [13] |
Li X, Dessi M, Marcus D, et al. Prediction of deep myometrial infiltration, clinical risk category, histological type, and lymphovascular space invasion in women with endometrial cancer based on clinical and T2-weighted MRI radiomic features [J]. Cancers, 2023, 15(8): 2209. DOI: 10.3390/cancers15082209.
|
| [14] |
Guo W, Wang T, Lyh B, et al. Advances in radiomics research for endometrial cancer: a comprehensive review [J]. J Cancer, 2023, 14(18): 3523-3531. DOI: 10.7150/jca.89347.
|
| [15] |
Ramirez PT, Frumovitz M, Pareja R, et al. Minimally invasive versus abdominal radical hysterectomy for cervical cancer[J]. New Engl J Med, 2018, 379(20): 1895-1904. DOI: 10.1056/NEJMoa1806395.
|
| [16] |
Raffone A, Travaglino A, Raimondo D, et al. Laparotomic versus robotic surgery in elderly patients with endometrial cancer: a systematic review and Meta-analysis [J]. Int J Gynecol Obstet, 2022, 157(1): 1-10. DOI: 10.1002/ijgo.13766.
|
| [17] |
Levin G, Brezinov Y, Brodeur MN, et al. Gynecologic oncology robot-assisted surgery in octogenarians: impact of age on hospital stay [J]. Int J Gynaecol Obstet, 2024, 167(2): 784-788. DOI: 10.1002/ijgo.15688.
|
| [18] |
Matanes E, Eisenberg N, Mitric C, et al. Surgical and oncological outcomes of sentinel lymph node sampling in elderly patients with intermediate to high-risk endometrial carcinoma [J]. Int J Gynecol Cancer, 2022, 32(7): 875-881. DOI: 10.1136/ijgc-2022-003431.
|
| [19] |
Matsuo K, Klar M, Khetan VU, et al. Sentinel lymph node biopsy for stage Ⅱ endometrial cancer: recent utilization and outcome in the United States [J]. Gynecol Oncol, 2022, 164(1): 46-52. DOI: 10.1016/j.ygyno.2021.10.085.
|
| [20] |
Schlappe BA, Weaver AL, McGree ME, et al. Multicenter study comparing oncologic outcomes after lymph node assessment via a sentinel lymph node algorithm versus comprehensive pelvic and paraaortic lymphadenectomy in patients with serous and clear cell endometrial carcinoma [J]. Gynecol Oncol, 2020, 156(1): 62-69. DOI: 10.1016/j.ygyno.2019.11.002.
|
| [21] |
González-Loyola A, Petrova TV. Development and aging of the lymphatic vascular system [J]. Adv Drug Deliv Rev, 2021, 169: 63-78. DOI: 10.1016/j.addr.2020.12.005.
|
| [22] |
Tortorella L, Casarin J, Multinu F, et al. Sentinel lymph node biopsy with cervical injection of indocyanine green in apparent early-stage endometrial cancer: predictors of unsuccessful mapping [J]. Gynecol Oncol, 2019, 155(1): 34-38. DOI: 10.1016/j.ygyno.2019.08.008.
|
| [23] |
|
| [24] |
Hughes CG, Boncyk CS, Culley DJ, et al. Postoperative delirium: a consensus statement from the Sixth Perioperative Quality Initiative (POQI-6) Workgroup [J]. Anesth Analg, 2020, 130(6): 1573-1588. DOI: 10.1213/ANE.0000000000004704.
|
| [25] |
Ou-Yang CL, Ma LB, Wu XD, et al. Association of sleep quality on the night of operative day with postoperative delirium in elderly patients: a prospective cohort study [J]. Eur J Anaesthesiol, 2024, 41(3): 226-233. DOI: 10.1097/EJA.0000000000001952.
|
| [26] |
Winterhoff B, Thomaier L, Mullany S, et al. Molecular characterization of endometrial cancer and therapeutic implications [J]. Curr Opin Obstet Gynecol, 2020, 32(1): 76-83. DOI: 10.1097/GCO.0000000000000602.
|
| [27] |
Concin N, Matias-Guíu X, Vergote I, et al. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma [J]. Int J Gynecol Cancer, 2021, 31(1): 12-39. DOI: 10.1136/ijgc-2020-002230.
|
| [28] |
Travaglino A, Raffone A, Mollo A, et al. TCGA molecular subgroups and FIGO grade in endometrial endometrioid carcinoma [J]. Arch Gynecol Obstet, 2020, 301(5): 1117-1125. DOI: 10.1007/s00404-020-05531-4.
|
| [29] |
MacKay HJ, Winterhoff B, Thomaier L, et al. Therapeutic targets and opportunities in endometrial cancer: update on endocrine therapy and nonimmunotherapy targeted options [J]. Am Soc Clin Oncol Educ Book, 2020, 40: 245-255. DOI: 10.1200/EDBK_280495.
|
| [30] |
Gupta S, Gupta R, Motwani V, et al. Adjuvant therapy for endometrial cancer in the era of molecular classification [J]. J Midlife Health, 2024, 15(3): 142-152. DOI: 10.4103/jmh.jmh_88_24.
|